SEC Filing Summary for AbbVie Inc. (ABBV)

This filing details a transaction by Brett J. Hart, a director at AbbVie Inc. (ABBV), on May 8, 2026. Mr. Hart acquired 1118 restricted stock units (RSUs) under the AbbVie Amended and Restated 2013 Incentive Stock Program. These RSUs will be settled in shares of AbbVie common stock on a one-to-one basis. The settlement will occur upon the earliest of Mr. Hart's separation from service, death, or a change in control, as defined by the Program. Following this acquisition, Mr. Hart holds 20,590 shares. The transaction code "A" indicates an acquisition, and the price per share is reported as $0.0, consistent with the nature of RSU awards. The filing is Form 4, indicating a change in beneficial ownership.